NCT03410862View on ClinicalTrials.gov

Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

June 25, 2019

Study Completion Date

June 25, 2019

Conditions
Influenza, Human
Interventions
DRUG

Elderberry Extract

Thick reddish-brown liquid of Sambucus Nigra (Black Elderberry)

DRUG

Placebos

Thick reddish-brown liquid similar in appearance and taste to Elderberry Extract not containing elderberry

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

Pharmacare Laboratories
All Listed Sponsors
collaborator

Pharmacare Laboratories

INDUSTRY

lead

michael macknin

OTHER

NCT03410862 - Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza | Biotech Hunter | Biotech Hunter